SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Aringer, M
Right arrow Articles by Stucki, G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aringer, M
Right arrow Articles by Stucki, G
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ICF Core Sets: how to specify impairment and function in systemic lupus erythematosus

M Aringer

Department of Rheumatology, Internal Medicine III, Medical University of Vienna Austria, Martin.Aringer{at}meduniwien.ac.at

T A Stamm

Department of Rheumatology, Internal Medicine III, Medical University of Vienna Austria, ICF Research Branch of the WHO Collaborating Center for the Family of International Classifications at the German Institute of Medical Documentation and Information (DIMDI), IMBK, Munich, Germany, Department of Physical Medicine and Rehabilitation, Ludwig-Maximilians-University, Munich, Germany

D S Pisetsky

Medical Research Service, Durham VA Hospital, Durham, NC, USA, Division of Rheumatology and Immunology, Duke University Medical Center, Durham, NC, USA

C H Yarboro

National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, MD, USA

A Cieza

ICF Research Branch of the WHO Collaborating Center for the Family of International Classifications at the German Institute of Medical Documentation and Information (DIMDI), IMBK, Munich, Germany

J S Smolen

Department of Rheumatology, Internal Medicine III, Medical University of Vienna Austria, Department of Medicine II, Lainz Hospital, Vienna, Austria

G Stucki

ICF Research Branch of the WHO Collaborating Center for the Family of International Classifications at the German Institute of Medical Documentation and Information (DIMDI), IMBK, Munich, Germany, Department of Physical Medicine and Rehabilitation, Ludwig-Maximilians-University, Munich, Germany

The World Health Organization’s International Classification of Function (ICF) is a tool to characterize and illuminate better the full of array of problems a patient faces when affected by disease. Specifying these problems is a particular challenge in a disease like systemic lupus erythematosus (SLE) because of the wide variety in organ systems involved, its variable activity and severity, and considerable ethnic and local differences. The authors of this manuscript believe, however, that a broader understanding will prove essential for optimal patient care, and that there is sufficient experience now in defining ICF Core Sets to successfully complete core sets for SLE. Therefore, we will embark on an international project for developing ICF Core Sets for SLE, which we here delineate. This development will include two versions: 1) The Brief ICF Core Set for SLE will be a very focused list of categories essential for SLE clinical trials; and 2) The Comprehensive ICF Core Set will be much broader and useful for guiding multidisciplinary assessment in patients with SLE. Both Core Sets will be developed in a formal decision-making and consensus process of health professionals integrating evidence gathered from preliminary studies. The final definition of the Core Sets will occur at a consensus conference which will integrate: i) a systematic review of the literature regarding the outcome measures used in clinical trials and selected observational studies; ii) focus groups or semi-structured interviews with SLE patients; iii) a Delphi exercise with world wide involvement of experts; and iv) the evidence from empirical studies. The development of these SLE ICF Core Sets is designed to be an inclusive, open, worldwide process. We therefore invite both SLE clinical experts and SLE patients to participate actively.

Key Words: impairment • quality of life • systemic lupus erythematosus • World Health Organization

Lupus, Vol. 15, No. 4, 248-253 (2006)
DOI: 10.1191/0961203306lu2298xx


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Neurorehabil Neural RepairHome page
M. Bernabeu, S. Laxe, R. Lopez, G. Stucki, A. Ward, M. Barnes, N. Kostanjsek, G. Reed, R. Tate, J. Whyte, et al.
Developing Core Sets for Persons With Traumatic Brain Injury Based on the International Classification of Functioning, Disability, and Health
Neurorehabil Neural Repair, June 1, 2009; 23(5): 464 - 467.
[Abstract] [PDF]



Advertisement